載入...
Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk
PURPOSE: Women with a family history of breast cancer are frequently referred for hereditary cancer genetic testing, yet < 10% are found to have pathogenic variants in known breast cancer susceptibility genes. Large-scale genotyping studies have identified common variants (primarily single-nucleo...
Na minha lista:
| 發表在: | JCO Precis Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Clinical Oncology
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7446363/ https://ncbi.nlm.nih.gov/pubmed/32923876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.19.00360 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|